Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
AGL · against 1,336 other Healthcare companies
Ranked #953 of 1,337 · scores higher than 8% of peers
Bars: peers in each 10-point band of the valuation score385 peers with a valuation score of 0–9, including AGL · Click a bar to see the companies
Mainly because of its EBITDA yield, earnings yield and free cash flow yield, which are weaker than most Healthcare peers.
| Metric | AGL | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 1,287 reported | -17.6% | 1.5% | 14% | 30% | |
| EBITDA yieldHigher is better · 1,357 reported | -18.1% | 4.2% | 11% | 50% | |
| Free cash flow yieldHigher is better · 711 reported | -7.2% | -1.0% | 33% | 20% | |
| Book yieldHigher is better · 1,306 reported | 15.4% | 37.9% | 22% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 21.3B HKD (≈$2.7B) | 99 | 68 | |
| 1 | 1.1B HKD (≈$146M) | 99 | 72 | |
| 1 | 14.2B HKD (≈$1.8B) | 99 | 64 | |
| 1 | 52.2B HKD (≈$6.7B) | 99 | 56 | |
| 1 | 3.5B HKD (≈$451M) | 99 | 51 | |
| 953 | 551M USD | 8 | 20 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score
| 953 | 198M USD | 8 | 10 |
| 953 | 4.1B USD | 8 | 39 |
| 953 | 1.9B USD | 8 | 49 |
| 953 | 1.5B USD | 8 | 26 |
| 953 | 201M USD | 8 | 24 |
| 953 | 831M USD | 8 |
| 953 | 37M USD | 8 | 21 |
| 953 | 387M USD | 8 | 49 |